Congenital Heart Disease Treatment Market: Introduction

  • Congenital heart disease is a structural heart issue existing at the time of birth. It is one of the most common types of birth defects across the globe.
  • In congenital heart disease, structure of the heart is developed abnormally. This includes defective heart valves, weak heart valves, and poor thickness of the heart arteries and veins. The abnormal heart structure leads to several complications such as low blood flow through the heart, blood flow in a wrong direction, and blockage of blood flow.
  • Congenital heart disease can be diagnosed through physical examination and special heart tests. It can also be diagnosed during pregnancy.
  • Common symptoms of congenital heart disease include poor blood circulation, rapid breathing, cyanosis, and fatigue. Most patients with the congenital heart disease show very less or no symptoms at early stages of the disease.
  • The treatment of congenital heart disease includes use of drugs, catheter procedure, surgery, and heart transplant

Are you a Start-up willing to make it big in the Business? Grab an Exclusive PDF Brochure of Congenital Heart Disease Treatment Market Report

Global Congenital Heart Disease Treatment Market: Key Drivers

  • The global congenital heart disease treatment market is primarily driven by rise in the rate of incidence of congenital heart disease and launch of new products across the globe. The Centers for Disease Control and Prevention (CDC) estimates that one million children and one million adults in the U.S. are living with congenital heart disease currently.
  • Also, advancements in early diagnosis of congenital heart disease and availability of new therapeutic drugs are likely to fuel the global congenital heart disease treatment market during the forecast period
  • The family history of congenital heart disease and presence of underlying medical conditions, such as rubella, Type-1 diabetes, and Type-2 diabetes, during pregnancy increase chances of developing congenital heart disease in babies

ACE Inhibitors Segment to Dominate Global Market

  • Based on drug class, the global congenital heart disease treatment market can be divided into angiotensin-converting enzyme inhibitors (ACE inhibitors), angiotensin receptor blockers, antiarrhythmics, anticoagulants, antiplatelets, beta blockers, bosentan, digoxin, diuretics, sildenafil, and warfarin. The ACE inhibitors segment is anticipated to dominate the global market during the forecast period.
  • ACE inhibitors are most commonly used for the treatment of high blood pressure and congestive heart failure. The most commonly prescribed ACE inhibitors are captopril, enalapril, lisinopril, ramipril, and trandolapril.

Retail Pharmacy Segment to Dominate Global Market

  • In terms of distribution channel, the global congenital heart disease treatment market can be segmented into hospital pharmacy, retail pharmacy, and online pharmacy. The retail pharmacy segment is projected to dominate the global congenital heart disease treatment market during the forecast period.
  • Easy availability of drugs for the treatment of congenital heart disease at retail pharmacy stores, presence of a large number of retail pharmacy stores across the globe, and rapidly growing number of retail pharmacy chains are factors responsible for the leading share of the retail pharmacy segment

Congenital Heart Disease Treatment Market in Asia Pacific to Expand Rapidly

  • In terms of region, the global congenital heart disease treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global market during the forecast period. However, the region is anticipated to lose market share by 2027.
  • High prevalence of congenital heart disease among people in the U.S., technological advancements in early diagnosis of the disease, and increase in awareness about congenital heart disease in the region are projected to drive the market in North America from 2019 to 2027
  • The congenital heart disease treatment market in Asia Pacific is projected to expand at a high CAGR during the forecast period, owing to rapid increase in the number of patients with congenital heart disease, high prevalence of diabetes in densely populated countries such as India, China, and South Korea, and rapidly improving health care infrastructure in the region

Expanding Operations in Future? To Get the Perfect Launch Ask for a Custom Congenital Heart Disease Treatment Market Report

Key Players Operating in Global Market

The global congenital heart disease treatment market is highly fragmented, with a large number of global players accounting for a major share of the market in respective regions. Key players operating in the global congenital heart disease treatment market are:

  • Novartis AG
  • Bayer AG
  • Merck & Co. Inc.
  • Johnson & Johnson
  • Pfizer Inc.
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Abbott
  • Orion Corporation
  • Cardiorentis Ag

Global Congenital Heart Disease Treatment Market: Research Scope

Global Congenital Heart Disease Treatment Market, by Drug Class

  • Angiotensin-converting Enzyme Inhibitors (ACE Inhibitors)
  • Angiotensin Receptor Blockers
  • Antiarrhythmics
  • Anticoagulants
  • Antiplatelets
  • Beta Blockers
  • Bosentan
  • Digoxin
  • Diuretics
  • Sildenafil
  • Warfarin

Global Congenital Heart Disease Treatment Market, by Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Global Congenital Heart Disease Treatment Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

Disclaimer: This ongoing market research study is a meticulously planned activity where a broad array of factors and aspects that shape the marketing environment and industry are taken into account. However, keeping in mind the constantly changing nature of business dynamics and changing strategic intents, we are always actively making iterations and modifications in our approaches. As always, we are ready to tailor our insights and guidance to suit your requirements. Engage with us to know what more is there for your CXOs.

Enquiry Before Buying

TMR offers Enquiry Before Buying that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Congenital Heart Disease Treatment Market